Yeast Transformant Production Using Recombinase Marker Excision

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for integrating target genes into yeast hosts are inefficient, particularly when using linear vectors, and require complex verification steps to ensure accurate integration and deletion of nucleic acid fragments.

Innovation Solution

A method utilizing site-specific recombinases and recognition sequences to integrate and delete nucleic acid fragments in yeast hosts, where at least one recognition sequence is provided in a fragment other than the target gene, allowing for simple evaluation of accurate integration based on target gene expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a linear vector is used to introduce a target gene into yeast host via homologous recombination, then the target gene can be integrated into the genome, but the efficiency of preparing transgenic yeast is very low (approximately 10^-6)

Engineering Contradiction:
Improveefficiency of preparing transgenic yeastVSAvoidintegration success rate
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The nucleic acid fragment is divided into three segments: an upstream region fragment with a 5' homologous recombination sequence, a target gene fragment, and a downstream region fragment with a 3' homologous recombination sequence. This segmentation allows each fragment to be independently designed and optimized for its specific function, improving overall integration efficiency

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Homologous recombination sequences are预先 (pre) provided at the ends of nucleic acid fragments before introduction into the host. These pre-designed homologous regions enable direct integration into the genome without requiring additional processing steps during transformation, thereby increasing efficiency

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If multiple nucleic acid fragments are introduced into the host to integrate a target gene at a particular site, then the target gene can be precisely located, but it becomes complicated to determine whether accurate integration has occurred

Engineering Contradiction:
Improveprecision of target gene integration siteVSAvoidcomplexity of integration verification
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

A selection marker gene is introduced as an intermediary element within the nucleic acid fragment structure. This marker gene serves as a verifiable indicator that the entire construct (including upstream and downstream regions) has been correctly integrated into the genome at the intended site

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The selection marker gene provides immediate feedback on integration success through selectable phenotypes. Only cells that have correctly integrated the complete nucleic acid fragment construct (with marker gene) will survive under selective conditions, automatically verifying accurate integration without complex additional assays

Inventive Principle:
Principle #23Feedback

3Ease of manufacture

If a selection marker gene is located between homologous recombination sequences to enable removal, then the marker can be removed after integration, but the process becomes more complex

Engineering Contradiction:
Improveease of marker removalVSAvoidcomplexity of multi-step process
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The selection marker gene removal function is merged with the site-specific recombination system. The same recombination sequences (loxP or FRT) used for initial integration are also used to remove the marker gene, combining two functions (integration and marker removal) into a unified system that uses the same molecular machinery

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The nucleic acid fragment construct is designed to be self-sufficient by including all necessary elements (homologous recombination sequences, target gene, selection marker, and site-specific recombination sequences) in a single integrated structure. This self-contained design enables the fragment to autonomously integrate into the genome and subsequently allow marker removal without requiring additional external components

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient production of transformants by ensuring accurate integration and deletion of nucleic acid fragments, simplifying the verification process and facilitating the marker recycle method.

Implementation Method 1

A site-specific recombinase is an enzyme that has activity of recognizing a particular, short, homologous pair of nucleotide sequences and causing homologous recombination between the pair of nucleotide sequences

Methodology Applied
Scientific EffectHomologous recombination:

Implementation Method 2

a nucleic acid fragment having either one of the pair of homologous recombination sequences corresponding to a particular region of genome DNA, and a nucleic acid fragment having the other of the pair of homologous recombination sequences into a host cell

Methodology Applied
Scientific EffectHomologous recombination:

Data Source

PatentUS12618084B2Method for producing transformant
Publication Date: 2026.05.05 TOYOTA JIDOSHA KK
  • US12618084B2 patent drawing
  • US12618084B2 patent drawing
  • US12618084B2 patent drawing

AI summary

The present disclosure concerns evaluation as to whether or not a nucleic acid fragment having a target gene had been accurately integrated into the host genome. A group of nucleic acid fragments comprising a nucleic acid fragment having a target gene is introduced into host cells, and host cells in which the target gene had been cleaved from the genome DNA by the action of a site-specific recombinase are selected.